Online Course: Introduction to Respiratory Dialysis

22 December 2014 Recent News

You can now view all three Respiratory Dialysis webinars presented by ECCO2R expert Dr. Vito Fanelli. Dr. Fanelli is an assistant professor of Anesthesia and Critical Care Medicine at the University of Turin. Part 1: Physiology of Extracorporeal CO2 Removal Part 2: Applications in Acute Exacerbation of COPD Part 3: ECCO2R in ARDS (read more)

Introduction to Respiratory Dialysis: ECCO2R in ARDS

7 November 2014 Webinars

In this third part of our online course “Introduction to Respiratory Dialysis – ECCO2R in ARDS,” ECCO2R expert Dr. Vito Fanelli will present the applications of extracorporeal CO2 removal in ARDS. From December 10, 2014 (read more)

Updates on Respiratory Dialysis – October 2014

10 October 2014 Recent News

The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS. New Case Report: Use of Respiratory Dialysis to Enable Lung Protective Ventilation in a Patient with Moderate ARDS due to Crush Syndrome from a Mining Accident A 41 year old male copper mine worker who developed moderate acute respiratory distress syndrome (ARDS) (read more)

Introduction to Respiratory Dialysis: Applications in Acute Exacerbation of COPD

9 October 2014 Webinars

In this second part of our online course “Introduction to Respiratory Dialysis – Applications in Acute Exacerbation of COPD,” ECCO2R expert Dr. Vito Fanelli will present the applications of extracorporeal CO2 removal in acute exacerbation of COPD. From October 30, 2014 (read more)

Introduction to Respiratory Dialysis: Physiology of Extracorporeal CO2 Removal

8 October 2014 Webinars

In this first part of our online course “Introduction to Respiratory Dialysis – From Physiology to Practice,” ECCO2R expert Dr. Vito Fanelli presents the physiology of CO2 clearance in critical care followed by a discussion of indications for extracorporeal CO2 removal (ECCO2R). From September 25, 2014 (read more)

Use of Respiratory Dialysis to Enable Lung Protective Ventilation in a Patient with Moderate ARDS due to Crush Syndrome from a Mining Accident: A case report

24 September 2014 User Reports

Dr. Jakub Smiechowicz, Dr. Barbara Barteczko Department of Anesthesiology and Intensive Therapy, Wroclaw University Hospital, Poland This report describes the case of a 41 year old male copper mine worker who developed moderate acute respiratory distress syndrome (ARDS) after being crushed and buried by falling stones in a mine accident. The patient became septic and difficult to (read more)

Updates on Respiratory Dialysis – September 2014

26 August 2014 Recent News

The latest news and developments related to extracorporeal CO2 removal and the Hemolung RAS. Opportunities for ECCO2R Education ESICM Pre-Course: Fundamentals of Extracorporeal CO2 Removal Sunday 28 September 2014 1:30 PM to 4:00 PM Hotel Barceló Atenea Mar, Barcelona Join us for this special pre-ESICM educational event in Barcelona! “Fundamentals of Extracorporeal CO2 Removal (ECCO2R)” will address practical questions about ECCO2R (read more)

ALung Recruiting Nurse User Group

11 August 2014 Recent News

Note: Registration for these sessions is now closed. ALung is recruiting ICU nurses to be part of a User Advisory Group. Participants will work directly with ALung’s engineering and clinical staff, helping test new designs and enhancements of the Hemolung RAS. We have an immediate need for 10 nurses to participate in user testing sessions (read more)

First US Patient Supported with the Hemolung RAS

2 July 2014 Recent News

Suffering from cystic fibrosis and rejecting the transplanted lungs he had gotten just two years ago, Jon Sacker, 33, came to UPMC in Pittsburgh from his hometown in Moore, Oklahoma, as a last resort. But when his carbon dioxide levels spiked, he became too sick to be immediately relisted for transplant. He was also too (read more)

First US Patient Supported with the Hemolung RAS

1 July 2014 Press Release

Pittsburgh, PA (July 2, 2014) – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, issued the following statement today from ALung Chairman and CEO Peter DeComo: “Yesterday, the Associated Press reported on the first ever use of our Hemolung RAS in the (read more)